IMPACT BIOMEDICAL INC (IBO) Stock Price, Quote, News and Overview
NYSEARCA:IBO - NYSE Arca - US45259L2051 - Common Stock - Currency: USD
IBO Quote, Performance and Key Statistics
NYSEARCA:IBO (5/2/2025, 11:25:10 AM)
0.802
+0.4 (+100.5%)
The current stock price of IBO is 0.802 USD. In the past month the price decreased by -29.82%.
IBO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 59.96 | 782.20B | ||
| JNJ | JOHNSON & JOHNSON | 15.44 | 373.85B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.83 | 304.52B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.72 | 225.17B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.24 | 221.85B | ||
| MRK | MERCK & CO. INC. | 10.73 | 210.29B | ||
| PFE | PFIZER INC | 7.49 | 136.37B | ||
| SNY | SANOFI-ADR | 14.37 | 135.75B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.79 | 101.50B | ||
| GSK | GSK PLC-SPON ADR | 7.04 | 78.46B | ||
| ZTS | ZOETIS INC | 26.51 | 70.00B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.29 | 48.20B |
Related stock screener links
About IBO
Company Profile
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.
Company Info
IMPACT BIOMEDICAL INC
1400 Broadfield Blvd., Suite 130
Houston TEXAS US
Employees: 2
Company Website: https://www.impactbiomedinc.com/
Investor Relations: http://investors.impactbiomedinc.com/
Phone: 15852321500
IMPACT BIOMEDICAL INC / IBO FAQ
What is the stock price of IMPACT BIOMEDICAL INC today?
The current stock price of IBO is 0.802 USD. The price increased by 100.5% in the last trading session.
What is the ticker symbol for IMPACT BIOMEDICAL INC stock?
The exchange symbol of IMPACT BIOMEDICAL INC is IBO and it is listed on the NYSE Arca exchange.
On which exchange is IBO stock listed?
IBO stock is listed on the NYSE Arca exchange.
What is IMPACT BIOMEDICAL INC worth?
IMPACT BIOMEDICAL INC (IBO) has a market capitalization of 9.70M USD. This makes IBO a Nano Cap stock.
How many employees does IMPACT BIOMEDICAL INC have?
IMPACT BIOMEDICAL INC (IBO) currently has 2 employees.
What are the support and resistance levels for IMPACT BIOMEDICAL INC (IBO) stock?
IMPACT BIOMEDICAL INC (IBO) has a resistance level at 0.44. Check the full technical report for a detailed analysis of IBO support and resistance levels.
Should I buy IMPACT BIOMEDICAL INC (IBO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IBO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IBO, evaluating the profitability, health, valuation and growth aspects
- IMPACT BIOMEDICAL INC (IBO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IMPACT BIOMEDICAL INC (IBO) Sales and EPS estimates to see what analysts future expectations are.
- IMPACT BIOMEDICAL INC (IBO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IMPACT BIOMEDICAL INC (IBO) Insider and Institutional Ownership to learn about the owners and their transactions.
- IMPACT BIOMEDICAL INC (IBO) Stock Chart to make your own analysis
- IMPACT BIOMEDICAL INC (IBO) Latest news and press-releases to stay up to date.
Does IMPACT BIOMEDICAL INC (IBO) stock pay dividends?
IBO does not pay a dividend.
What is the Price/Earnings (PE) ratio of IMPACT BIOMEDICAL INC (IBO)?
IMPACT BIOMEDICAL INC (IBO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.46).
What is the Short Interest ratio of IMPACT BIOMEDICAL INC (IBO) stock?
The outstanding short interest for IMPACT BIOMEDICAL INC (IBO) is 1.68% of its float. Check the ownership tab for more information on the IBO short interest.
IBO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to IBO.
IBO Financial Highlights
Over the last trailing twelve months IBO reported a non-GAAP Earnings per Share(EPS) of -2.46. The EPS decreased by -509.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -121.79% | ||
| ROE | -580.23% | ||
| Debt/Equity | 2.08 |